“木郁达之”理论在子宫内膜异位症相关性疼痛中的应用发微
A Theoretical Exploration of the Application of “Mu Yu Da Zhi” Theory in Endometriosis-Related Pain
DOI: 10.12677/tcm.2026.1510555, PDF,   
作者: 毛佳丽, 符铭阳, 栾 兰, 乔 虹:黑龙江中医药大学研究生院,黑龙江 哈尔滨;张天婵*:黑龙江中医药大学附属第二医院妇一科,黑龙江 哈尔滨
关键词: 木郁达之;子宫内膜异位症;疼痛;Mu Yu Da Zhi; Endometriosis; Pain
摘要: “木郁达之”理论是中医妇科疼痛性疾病诊疗的核心法则,对子宫内膜异位症(EMS)相关性疼痛的机制阐释与临床干预具有重要指导价值。本文首先对该理论进行学术溯源,厘清其“木郁”为病机之本、“达之”为治疗之要的核心内涵。进而从病机发微角度,提出肝郁气滞为发病之始,血瘀胞宫为病理之标,并深入剖析了“木郁克土”致痰瘀互结的病机转化过程,阐释了其与疼痛发生的内在关联。在治疗层面,强调“达之之法”重在调气、活血、通络,并主张结合月经周期进行分期论治。此外,本文系统整合了现代生物学研究成果,从神经–内分泌–免疫网络调控、血管生成与微循环改善、炎症因子与免疫清除、细胞凋亡与自噬等多个维度,阐释了“木郁达之”干预EMS疼痛的现代生物学机制。通过古今文献的系统梳理与深度结合,本文旨在为EMS相关性疼痛的精准治疗提供理论参考,为“木郁达之”理论的现代转化与临床应用提供思路。
Abstract: The theory of “Mu Yu Da Zhi” is the core principle of diagnosis and treatment of gynecological pain diseases in traditional Chinese medicine, which has important guiding value for the mechanism explanation and clinical intervention of endometriosis-related pain. Firstly, this paper traces the academic origin of the theory and clarifies its core connotation that “wood depression” is the root of pathogenesis and “reaching it” is the key to treatment. Furthermore, from the perspective of elucidating the pathogenesis, it was pointed out that stagnation of liver qi marked the onset of the disease, and blood stasis in uterus was the pathological manifestation. Furthermore, the pathogenesis transformation process of intertwined phlegm and blood stasis caused by “wood depression conquers earth” was deeply analyzed, and its internal relationship with pain was explained. At the level of treatment, it is emphasized that the “Dazhi method” focuses on regulating qi, activating blood circulation and dredging collaterals, and it is advocated to treat by stages according to the menstrual cycle. In addition, this paper systematically integrates the research results of modern biology, and explains the modern biological mechanism of “Mu Yu Da Zhi” intervention in EMS pain from the dimensions of neuro-endocrine-immune network regulation, angiogenesis and microcirculation improvement, inflammatory factors and immune clearance, apoptosis and autophagy. Through the systematic combing and deep combination of ancient and modern literature, this paper aims to provide a useful theoretical reference for the precise treatment of EMS-related pain, and provide ideas for the modern transformation and clinical application of the theory of “Mu Yu Da Zhi”.
文章引用:毛佳丽, 符铭阳, 栾兰, 乔虹, 张天婵. “木郁达之”理论在子宫内膜异位症相关性疼痛中的应用发微[J]. 中医学, 2026, 15(10): 276-284. https://doi.org/10.12677/tcm.2026.1510555

参考文献

[1] 陈景伟, 刘慧敏, 马艺鸣. 子宫内膜异位症相关疼痛中医诊疗指南[J]. 中华中医药学刊, 2024, 42(5): 250-258.
[2] 郎景和, 子宫内膜异位症的基础与临床问题研究[Z]. 北京: 北京协和医院, 2011.
[3] 刘兴武. 纵谈木郁达之与脏腑相传[J]. 中医杂志, 1996(3): 137-140+132.
[4] 杨威, 陈希成, 王霜, 等. 《黄帝内经》“五郁”本义考释[J]. 中国中医基础医学杂志, 2021, 27(5): 705-710.
[5] 秦绍林, 王玉来, 滕晶, 等. “时必顺之”与五郁之治[J]. 上海中医药杂志, 2008(1): 52-53.
[6] 段飞, 胡镜清. “木郁达之”理论沿革探析[J]. 环球中药, 2015, 8(8): 938-942.
[7] 文潮. 逍遥散“木郁达之”配伍在妇科运用探微[J]. 现代中医药, 2015, 35(5): 111-113.
[8] 王怡, 张继伟, 王浩, 等. 基于“木郁达之”运用乌梅丸治疗情志病撷要[J]. 江苏中医药, 2024, 56(2): 45-48.
[9] 区绮云. 疏肝理气法治疗子宫内膜异位症[J]. 河南中医, 2008(3): 68-69.
[10] 梅珊珊, 胡薇, 丁杰, 等. 598例疼痛性子宫内膜异位症患者证候要素特征的隐结构分析[J]. 浙江中医杂志, 2023, 58(8): 581-583.
[11] 熊婷, 杨新春, 赵瑞华. 从肝脾论治子宫内膜异位症[J]. 北京中医药, 2021, 40(12): 1361-1363.
[12] 杨颢雪, 汤伟伟, 刘迪芬, 等. 基于“炎-焦-瘀”探讨补肾活血法治疗子宫内膜异位症[J]. 中国医药导报, 2026, 23(9): 148-151+168.
[13] 李娜, 甘小金, 阙绮莹, 等. 王子瑜教授从“血瘀”论治子宫内膜异位性疾病经验[J]. 中国医药导报, 2024, 21(16): 152-154.
[14] 赵红艳, 刘金星. 从痰瘀论治子宫内膜异位症[J]. 辽宁中医药大学学报, 2010, 12(6): 154-155.
[15] 赵洁, 侯静雯, 王坤芳, 等. 基于“痰挟瘀血, 遂成窠囊”理论论治子宫内膜异位症经验探析[J]. 中医药临床杂志, 2025, 37(5): 915-918.
[16] 詹瑾, 蒋婴, 吴佳杰. 基于网络药理学与动物实验探讨当归芍药散调控PI3K/AKT信号通路改善子宫内膜异位症的作用机制[J]. 中国优生与遗传杂志, 2025, 33(6): 1261-1270.
[17] 李小平. 木达汤治疗子宫内膜异位症盆腔痛临床观察[J]. 光明中医, 2009, 24(11): 2102-2104.
[18] 柴华, 王嘉梅. 理气活血法治疗气滞血瘀型子宫内膜异位症痛经73例的临床效果[J]. 中国医药导报, 2015, 12(19): 89-92.
[19] 张春敏, 吴天思, 王颖颖, 等. 针灸治疗气虚血瘀型子宫内膜异位症痛经的效果分析[J]. 天津中医药大学学报, 2024, 43(5): 439-443.
[20] 张丽娜. 从瘀论治子宫内膜异位症疼痛的系统评价[D]: [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2010.
[21] 王焕焕, 李鹏辉, 徐玉慧. 解郁活血汤治疗子宫内膜异位症气滞血瘀型临床观察[J]. 实用中医药杂志, 2024, 40(2): 225-226.
[22] 尹宁, 张晓丹. 化瘀解郁方联合孕三烯酮胶囊治疗子宫内膜异位症痛经临床观察[J]. 实用中医药杂志, 2024, 40(4): 707-710.
[23] 张磊, 苏丽娜, 王春艳, 等. 名老中医黄素英论治子宫内膜异位症用药经验及经验撷菁[J]. 湖南中医药大学学报, 2025, 45(8): 1490-1494.
[24] 齐盈颊, 肖新春, 崔晓萍, 等. 基于伏邪、络病理论探讨子宫内膜异位症病因病机及治疗[J]. 江苏中医药, 2020, 52(9): 4-7.
[25] 强若男, 刘雁峰. 基于“寒气生浊”理论的子宫内膜异位症相关纤维化辨治思路探析[J]. 北京中医药大学学报, 2024, 47(9): 1185-1190.
[26] 陆黎娟, 曾薇薇, 刘迎, 等. 扶正通络方预防子宫内膜异位症术后复发及对免疫稳态影响的研究[J]. 现代中西医结合杂志, 2024, 33(5): 585-589.
[27] 高路益, 张悦健, 杨思晨, 等. 基于络病理论探讨通络祛痛法在子宫内膜异位症疼痛中的应用[J]. 中国性科学, 2023, 32(11): 132-135.
[28] 牛阿娜, 沈文迪, 章琪滢, 等. 子宫内膜异位症“阳虚瘀结”病机探析及温阳活血分期治疗实践[J]. 妇儿健康导刊, 2025, 4(9): 39-43.
[29] 夏馨, 陈旦平. 陈旦平运用调肾活血法治疗子宫内膜异位症经验[J]. 浙江中西医结合杂志, 2023, 33(9): 847-850.
[30] Przyśliwski, K., Pliszkiewicz, M., Jacko, J., Bogaczyk, A., Siekierski, B.P. and Kluz, T. (2026) Correlation between Pain Intensity in Different Locations and Intraoperative Stage of Endometriosis According to rASRM and #ENZIAN Classification. Journal of Clinical Medicine, 15, Article No. 2725.
https://doi.org/10.3390/jcm15072725
[31] 许金榜, 林丹玫, 林巧燕, 等. 芍药止痛合剂治疗ⅢⅣ期子宫内膜异位症临床研究[J]. 中国中医药信息杂志, 2014, 21(4): 26-30.
[32] 卢翠云, 齐荣义, 卢翠敏. 神经-内分泌-免疫网络在子宫内膜异位症发病机制中的作用[J]. 北京医学, 2004(2): 137-138.
[33] Chang, L., Shan, J., Li, D. and Wang, X. (2025) Neuroendocrine–immune Axis in Endometriosis: A Review on How the Nervous System Goes Beyond Pain Perception. Biomolecules, 15, Article No. 1536.
https://doi.org/10.3390/biom15111536
[34] Anchan, M.M. and Dutta, R. (2025) Reframing Endometriosis: Interplay of NETs, Macrophages, and Lymphocytes at the Crossroads of Disease Progression, Infertility, and Malignant Transformation. American Journal of Reproductive Immunology, 94, e70179.
https://doi.org/10.1111/aji.70179
[35] 陆黎娟, 曾薇薇, 王靖雯, 等. 内异停方通过TREM1/TLR4/NF-κB信号通路抑制巨噬细胞M1极化预防子宫内膜异位症术后复发[J]. 四川大学学报(医学版), 2025, 56(2): 371-381.
[36] 李卫红, 尹姝珂, 刘妍, 等. 蠲痛饮对子宫内膜异位症间质细胞TLR4/NF-κB通路的影响[J]. 时珍国医国药, 2025, 36(16): 3024-3031.
[37] Wu, L., Su, R., Jia, J., Kuang, Z., Zeng, C. and Pei, F. (2026) Mechanisms of Luoshi Neiyi Prescription (LSNYP) in Endometriosis: A Network Pharmacology and Experimental Study. Hereditas, 163, Article No. 24.
https://doi.org/10.1186/s41065-026-00637-2
[38] 赵军, 刘肖, 李亚里, 等. 低氧预处理对大鼠子宫内膜异位病灶形成的影响[J]. 南方医科大学学报, 2016, 36(10): 1369-1376.
[39] 贾桂蕾. HIF-1、VEGF在实验性大鼠子宫内膜异位症的表达及疏肝理气温阳化瘀法对其影响[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2011.
[40] 姜艳玲, 王金华, 李发余, 等. 丹白颗粒对子宫内膜异位症大鼠异位症血管生成及应激水平的影响[J]. 湖南中医药大学学报, 2022, 42(8): 1266-1270.
[41] 李小平, 林舒, 兰巧英. 疏肝理气化瘀法治疗复发性卵巢子宫内膜异位囊肿临床观察[J]. 光明中医, 2011, 26(7): 1364-1366.
[42] Williams, A.C., Content, V.G. and Alexander, L.M. (2025) Salsalate Negatively Impacts Microvascular Function in Women with Endometriosis. American Journal of Physiology—Heart and Circulatory Physiology, 328, H915-H922.
https://doi.org/10.1152/ajpheart.00012.2025
[43] 黄洁明, 欧阳惠卿, 许丽绵, 等. 子宫内膜异位症血瘀证本质探讨及罗氏内异方对其血管内环境的影响[J]. 河南中医, 2006(10): 23-25.
[44] 王燕. 活血化瘀法治疗子宫内膜异位症在激素及相关因素方面的研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2003.
[45] 徐晓娟. 化瘀止痛片对血瘀模型大鼠血液流变学和小鼠微循环的影响[J]. 成都中医药大学学报, 2004(4): 36-39.
[46] Oosterlynck, D.J., Cornillie, F.J., Waer, M., Vandeputte, M. and Koninckx, P.R. (1991) Women with Endometriosis Show a Defect in Natural Killer Activity Resulting in a Decreased Cytotoxicity to Autologous Endometrium. Fertility and Sterility, 56, 45-51.
https://doi.org/10.1016/s0015-0282(16)54414-8
[47] Saunders, P.T.K. and Horne, A.W. (2021) Endometriosis: Etiology, Pathobiology, and Therapeutic Prospects. Cell, 184, 2807-2824.
https://doi.org/10.1016/j.cell.2021.04.041
[48] Vallvé-Juanico, J., Houshdaran, S. and Giudice, L.C. (2019) The Endometrial Immune Environment of Women with Endometriosis. Human Reproduction Update, 25, 565-592.
https://doi.org/10.1093/humupd/dmz018
[49] Kobayashi, H., Imanaka, S., Yoshimoto, C., Matsubara, S. and Shigetomi, H. (2024) Molecular Mechanism of Autophagy and Apoptosis in Endometriosis: Current Understanding and Future Research Directions. Reproductive Medicine and Biology, 23, e12577.
https://doi.org/10.1002/rmb2.12577
[50] Tellez-Quijorna, C., Juan-Lopez, A., Eritja, N., Llobet-Navas, D. and Devis-Jauregui, L. (2025) Dysregulated Autophagy in Endometriosis: Molecular Mechanisms, Controversies, and Clinical Implications. Reproductive Biology and Endocrinology, 24, Article No. 8.
https://doi.org/10.1186/s12958-025-01494-w
[51] Zi, D., Sun, J., Zuo, N., Li, T., Liang, J., Hu, J., et al. (2026) Regulated Cell Death in Endometrial Diseases: From Molecular Mechanisms to Targeted Therapies. Archives of Toxicology, 100, 109-125.
https://doi.org/10.1007/s00204-025-04192-z
[52] 基于ROS介导NLRP3炎症小体通路探讨蠲痛饮对子宫内膜异位症大鼠自噬的作用机制[J]. 时珍国医国药, 2024, 35(9): 2086-2091.
[53] Lai, H., Jia, J., Kuang, Z., Lu, J. and Zeng, Y. (2025) Shaoyao Gancao Decoction Induces Autophagy by Modulating miR-21 and Inhibiting the AKT/mTOR Signaling Pathway in Adenomyosis-Derived Ectopic Endometrial Stromal Cells. Frontiers in Pharmacology, 16, Article ID: 1665911.
https://doi.org/10.3389/fphar.2025.1665911
[54] 黄艳辉, 丑丹, 冯丹, 等. 温经止痛方对子宫内膜异位症模型大鼠自嗜基因Beclin-1、LC3表达的影响[J]. 广州中医药大学学报, 2018, 35(5): 848-854.